The Effect of Acupressure on the Sleep Quality and Fatigue
Launched by MERSIN UNIVERSITY · Jun 5, 2021
Trial Information
Current as of June 03, 2025
Unknown status
Keywords
ClinConnect Summary
In this study, 68 nurses working in internal clinics were randomly assigned to acupressure and placebo (sham) acupressure groups. In the acupressure group (n=34), the heart meridian 7th point (HT7), large intestine meridian 4th point (LI4), stomach meridian 36th point (ST36) and spleen meridian 6th point (SP6) will be applied to a total of four points. Depending on the preparation and compression time on each point, the session duration of each nurse will be 20 minutes on average. In the sham group (n=34), pressure will be made approximately 1-1.5 cm away from the HT7, LI4, ST36, SP6 points...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Nurses who care for COVID 19 patients during the pandemic process
- • Nurses working in internal clinics during the data collection process
- • Those who have recovered from COVID 19
- • Those who agreed to participate in the study
- • No deformity or lesions in the areas where acupressure will be applied
- • No acupressure experience
- • No sleep disorder diagnosis and no medical treatment
- • Not diagnosed with anxiety disorder and not receiving medical treatment
- • Not diagnosed with depression and not receiving medical treatment
- • Coffee, cigarette and alcohol free
- • No mental disorder
- • Night shift workers
- • Those who can understand and speak Turkish
- • Those who signed the Informed Consent Form
- Exclusion Criteria:
- • Nurses who did not work in internal clinics during the data collection process
- • Nurses who do not care for COVID 19 patients during the pandemic process
- • Those with active COVID 19
- • Those who do not agree to participate in the study
- • Those who have any deformity or lesion in the areas where acupressure will be applied
- • Experiences of acupressure
- • Heart and kidney failure, severe anemia, immunodeficiency problem
- • Pregnant
- • Diagnosed with sleep disorder and receiving treatment
- • Anxiety disorder and treatment
- • Depression diagnosed and treated
- • Coffee, cigarette and alcohol addiction
- • Having mental illness
- • Fixed day shift workers
- • Those who can not understand and speak Turkish
- • Those who did not sign the Informed Consent Form
About Mersin University
Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mersin, Yenişehir, Turkey
Patients applied
Trial Officials
Meral Gun, Doctorate
Study Director
Mersin University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials